Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms

Author(s): Zhao X, Gan L, Pan H, Kan D, Majeski M, et al.

Abstract

FOXO1, a Forkhead transcription factor, is an important target of insulin and growth factor action. Phosphorylation of Thr-24, Ser-256 and Ser-319 promotes nuclear exclusion of FOXO1, yet the mechanisms regulating nuclear/cytoplasmic shuttling of FOXO1 are poorly understood. Previous studies have identified an NLS (nuclear localization signal) in the C-terminal basic region of the DBD (DNA-binding domain), and a leucine-rich, leptomycin-B sensitive NES (nuclear export signal) located further downstream. Here, we find that other elements in the DBD also contribute to nuclear localization, and that multiple mechanisms contribute to nuclear exclusion of FOXO1. Phosphorylation of Ser-319 and a cluster of nearby residues (Ser-322, Ser-325 and Ser-329) functions co-operatively with the nearby NES to promote nuclear exclusion. The N-terminal region of FOXO1 (amino acids 1-149) also is sufficient to promote nuclear exclusion, and does so through multiple mechanisms. Amino acids 1-50 are sufficient to promote nuclear exclusion of green fluorescent protein fusion proteins, and the phosphorylation of Thr-24 is required for this effect. A leucine-rich, leptomycin B-sensitive export signal is also present nearby. Phosphorylated FOXO1 binds 14-3-3 proteins, and co-precipitation studies with tagged proteins indicate that 14-3-3 binding involves co-operative interactions with both Thr-24 and Ser-256. Ser-256 is located in the C-terminal region of the DBD, where 14-3-3 proteins may interfere both with DNA-binding and with nuclear-localization functions. Together, these studies demonstrate that multiple elements contribute to nuclear/cytoplasmic shuttling of FOXO1, and that phosphorylation and 14-3-3 binding regulate the cellular distribution and function of FOXO1 through multiple mechanisms. The presence of these redundant mechanisms supports the concept that the regulation of FOXO1 function plays a critical role in insulin and growth factor action.

Similar Articles

Diabetes and the risk of heart failure

Author(s): Dhingra R, Vasan RS

Pathophysiology of myocardial reperfusion

Author(s): Fox KA, Bergmann SR, Sobel BE

Chronic pharmacological preconditioning against ischemia

Author(s): Luca MC, Liuni A, Muxel S, Münzel T, Forconi S, et al.

Myocardial fatty acid metabolism in health and disease

Author(s): Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC

FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress

Author(s): Sengupta A, Molkentin JD, Paik JH, DePinho RA, Yutzey KE

FoxO, autophagy, and cardiac remodeling

Author(s): Ferdous A, Battiprolu PK, Ni YG, Rothermel BA, Hill JA

The FoxO family in cardiac function and dysfunction

Author(s): Ronnebaum SM, Patterson C

Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice

Author(s): Battiprolu PK, Hojayev B, Jiang N, Wang ZV, Luo X, et al.

Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1

Author(s): Puthanveetil P, Zhang D, Wang Y, Wang F, Wan A, et al.

Altered acetylcholine and norepinephrine concentrations in diabetic rat hearts

Author(s): Akiyama N, Okumura K, Watanabe Y, Hashimoto H, Ito T, et al.

Glucose for the heart

Author(s): Depre C, Vanoverschelde JL, Taegtmeyer H

Hibernating myocardium

Author(s): Wijns W, Vatner SF, Camici PG

Risk of heart failure in patients with recent-onset type 2 diabetes: population-based cohort study

Author(s): Leung AA, Eurich DT, Lamb DA, Majumdar SR, Johnson JA, et al.

Phosphatases at the heart of FoxO metabolic control

Author(s): Tremblay ML, Giguère V

Adiponectin in the heart and vascular system

Author(s): Ding M, Rzucidlo EM, Davey JC, Xie Y, Liu R, et al.

The role of FoxO in the regulation of metabolism

Author(s): Gross DN, van den Heuvel AP, Birnbaum MJ

FoxO transcription factors; Regulation by AKT and 14-3-3 proteins

Author(s): Tzivion G, Dobson M, Ramakrishnan G

Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction

Author(s): Parisi Q, Biondi-Zoccai GG, Abbate A, Santini D, Vasaturo F, et al.

Silent information regulator 1 protects the heart from ischemia/reperfusion

Author(s): Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, et al.

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

Author(s): Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al.

Oxidative stress, nitric oxide, and diabetes

Author(s): Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, et al.

Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure

Author(s): Mehra A, Shotan A, Ostrzega E, Hsueh W, Vasquez-Johnson J, et al.

Influence of diabetes mellitus on heart failure risk and outcome

Author(s): Bauters C, Lamblin N, Mc Fadden EP, Van Belle E, Millaire A, et al.

Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism

Author(s): Philip-Couderc P, Tavares NI, Roatti A, Lerch R, Montessuit C, et al.

An essential role of the JAK-STAT pathway in ischemic preconditioning

Author(s): Xuan YT, Guo Y, Han H, Zhu Y, Bolli R

Preconditioning the diabetic heart: the importance of Akt phosphorylation

Author(s): Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM